US FDA Authorized AffaMed’s Bispecific Biologic for Treating Retinal Vascular Diseases

The company ‘AffaMed Therapeutics’, a clinical stage biotechnology company that is dedicated to the commercialization and development of the transformative pharmaceutical, surgical and digital products announced that, the Food and Drug Administration (FDA) of the United States has now cleared the application of the Investigational New Drug (IND) for the clinical development of the AM712, […]

Continue Reading

US FDA Approves New Monoclonal Antibody That is Effective Against Omicron Variant

The Food and Drug Administration (FDA) of the United States have given the authorization for a new monoclonal antibody treatment that is working effectively against the Omicron covid-19 variant. The emergency use authorization for the bebtelovimab has been for the treatment of the mild to moderate corona virus in the adults and pediatric patients around […]

Continue Reading